Association of cardiac troponin T and growth differentiation factor 15 with replacement and interstitial cardiac fibrosis in community dwelling adults: The multi-ethnic study of atherosclerosis

BackgroundSubclinical abnormalities in myocardial structure (stage B heart failure) may be identified by cardiac and non-organ specific biomarkers. The associations of high-sensitivity cardiac troponin T (hs-cTnT) and growth differentiation factor-15 (GDF-15) with cardiac magnetic resonance imaging...

Full description

Bibliographic Details
Main Authors: Christopher R. deFilippi, Henry Tran, Raghav Gattani, Lori B. Daniels, Palak Shah, Leonard Ilkhanoff, Robert Christenson, Joao A. Lima, Stephen Seliger
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-02-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2023.1104715/full
_version_ 1811167969950040064
author Christopher R. deFilippi
Henry Tran
Raghav Gattani
Lori B. Daniels
Palak Shah
Leonard Ilkhanoff
Robert Christenson
Joao A. Lima
Stephen Seliger
author_facet Christopher R. deFilippi
Henry Tran
Raghav Gattani
Lori B. Daniels
Palak Shah
Leonard Ilkhanoff
Robert Christenson
Joao A. Lima
Stephen Seliger
author_sort Christopher R. deFilippi
collection DOAJ
description BackgroundSubclinical abnormalities in myocardial structure (stage B heart failure) may be identified by cardiac and non-organ specific biomarkers. The associations of high-sensitivity cardiac troponin T (hs-cTnT) and growth differentiation factor-15 (GDF-15) with cardiac magnetic resonance imaging (CMR) interstitial fibrosis (extracellular volume [ECV]) is unknown and for GDF-15 the association with replacement (late gadolinium enhancement [LGE]) is also unknown. GDF-15 is a systemic biomarker also released by myocytes associated with fibrosis and inflammation. We sought to define the associations of hs-cTnT and GDF-15 with these CMR fibrosis measures in the MESA cohort.MethodsWe measured hs-cTnT and GDF-15 in MESA participants free of cardiovascular disease at exam 5. CMR measurements were complete in 1737 for LGE and 1258 for ECV assessment. We estimated the association of each biomarker with LGE and increased ECV (4th quartile) using logistic regression, adjusted for demographics and risk factors.ResultsMean age of the participants was 68 ± 9 years. Unadjusted, both biomarkers were associated with LGE, but after adjustment only hs-cTnT concentrations remained significant (4th vs. 1st quartile OR] 7.5, 95% CI: 2.1, 26.6). For interstitial fibrosis both biomarkers were associated with 4th quartile ECV, but the association was attenuated compared to replacement fibrosis. After adjustment, only hs-cTnT concentrations remained significant (1st to 4th quartile OR 1.7, 95%CI: 1.1, 2.8).ConclusionOur findings identify that both interstitial and replacement fibrosis are associated with myocyte cell death/injury, but GDF-15 a non-organ specific biomarker prognostic for incident cardiovascular disease is not associated with preclinical evidence of cardiac fibrosis.
first_indexed 2024-04-10T16:18:08Z
format Article
id doaj.art-6e19d9d3a1204e898df62423bad4c49e
institution Directory Open Access Journal
issn 2297-055X
language English
last_indexed 2024-04-10T16:18:08Z
publishDate 2023-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cardiovascular Medicine
spelling doaj.art-6e19d9d3a1204e898df62423bad4c49e2023-02-09T16:20:56ZengFrontiers Media S.A.Frontiers in Cardiovascular Medicine2297-055X2023-02-011010.3389/fcvm.2023.11047151104715Association of cardiac troponin T and growth differentiation factor 15 with replacement and interstitial cardiac fibrosis in community dwelling adults: The multi-ethnic study of atherosclerosisChristopher R. deFilippi0Henry Tran1Raghav Gattani2Lori B. Daniels3Palak Shah4Leonard Ilkhanoff5Robert Christenson6Joao A. Lima7Stephen Seliger8Inova Heart and Vascular Institute, Falls Church, VA, United StatesInova Heart and Vascular Institute, Falls Church, VA, United StatesInova Heart and Vascular Institute, Falls Church, VA, United StatesDivision of Cardiology, University of California and San Diego Medical Center, San Diego, CA, United StatesInova Heart and Vascular Institute, Falls Church, VA, United StatesInova Heart and Vascular Institute, Falls Church, VA, United StatesDepartment of Pathology, University of Maryland School of Medicine, Baltimore, MD, United StatesThe Johns Hopkins School of Medicine, Baltimore, MD, United StatesDepartment of Pathology, University of Maryland School of Medicine, Baltimore, MD, United StatesBackgroundSubclinical abnormalities in myocardial structure (stage B heart failure) may be identified by cardiac and non-organ specific biomarkers. The associations of high-sensitivity cardiac troponin T (hs-cTnT) and growth differentiation factor-15 (GDF-15) with cardiac magnetic resonance imaging (CMR) interstitial fibrosis (extracellular volume [ECV]) is unknown and for GDF-15 the association with replacement (late gadolinium enhancement [LGE]) is also unknown. GDF-15 is a systemic biomarker also released by myocytes associated with fibrosis and inflammation. We sought to define the associations of hs-cTnT and GDF-15 with these CMR fibrosis measures in the MESA cohort.MethodsWe measured hs-cTnT and GDF-15 in MESA participants free of cardiovascular disease at exam 5. CMR measurements were complete in 1737 for LGE and 1258 for ECV assessment. We estimated the association of each biomarker with LGE and increased ECV (4th quartile) using logistic regression, adjusted for demographics and risk factors.ResultsMean age of the participants was 68 ± 9 years. Unadjusted, both biomarkers were associated with LGE, but after adjustment only hs-cTnT concentrations remained significant (4th vs. 1st quartile OR] 7.5, 95% CI: 2.1, 26.6). For interstitial fibrosis both biomarkers were associated with 4th quartile ECV, but the association was attenuated compared to replacement fibrosis. After adjustment, only hs-cTnT concentrations remained significant (1st to 4th quartile OR 1.7, 95%CI: 1.1, 2.8).ConclusionOur findings identify that both interstitial and replacement fibrosis are associated with myocyte cell death/injury, but GDF-15 a non-organ specific biomarker prognostic for incident cardiovascular disease is not associated with preclinical evidence of cardiac fibrosis.https://www.frontiersin.org/articles/10.3389/fcvm.2023.1104715/fullbiomarkerstroponinGDF-15fibrosiscardiac diseaseheart failure
spellingShingle Christopher R. deFilippi
Henry Tran
Raghav Gattani
Lori B. Daniels
Palak Shah
Leonard Ilkhanoff
Robert Christenson
Joao A. Lima
Stephen Seliger
Association of cardiac troponin T and growth differentiation factor 15 with replacement and interstitial cardiac fibrosis in community dwelling adults: The multi-ethnic study of atherosclerosis
Frontiers in Cardiovascular Medicine
biomarkers
troponin
GDF-15
fibrosis
cardiac disease
heart failure
title Association of cardiac troponin T and growth differentiation factor 15 with replacement and interstitial cardiac fibrosis in community dwelling adults: The multi-ethnic study of atherosclerosis
title_full Association of cardiac troponin T and growth differentiation factor 15 with replacement and interstitial cardiac fibrosis in community dwelling adults: The multi-ethnic study of atherosclerosis
title_fullStr Association of cardiac troponin T and growth differentiation factor 15 with replacement and interstitial cardiac fibrosis in community dwelling adults: The multi-ethnic study of atherosclerosis
title_full_unstemmed Association of cardiac troponin T and growth differentiation factor 15 with replacement and interstitial cardiac fibrosis in community dwelling adults: The multi-ethnic study of atherosclerosis
title_short Association of cardiac troponin T and growth differentiation factor 15 with replacement and interstitial cardiac fibrosis in community dwelling adults: The multi-ethnic study of atherosclerosis
title_sort association of cardiac troponin t and growth differentiation factor 15 with replacement and interstitial cardiac fibrosis in community dwelling adults the multi ethnic study of atherosclerosis
topic biomarkers
troponin
GDF-15
fibrosis
cardiac disease
heart failure
url https://www.frontiersin.org/articles/10.3389/fcvm.2023.1104715/full
work_keys_str_mv AT christopherrdefilippi associationofcardiactroponintandgrowthdifferentiationfactor15withreplacementandinterstitialcardiacfibrosisincommunitydwellingadultsthemultiethnicstudyofatherosclerosis
AT henrytran associationofcardiactroponintandgrowthdifferentiationfactor15withreplacementandinterstitialcardiacfibrosisincommunitydwellingadultsthemultiethnicstudyofatherosclerosis
AT raghavgattani associationofcardiactroponintandgrowthdifferentiationfactor15withreplacementandinterstitialcardiacfibrosisincommunitydwellingadultsthemultiethnicstudyofatherosclerosis
AT loribdaniels associationofcardiactroponintandgrowthdifferentiationfactor15withreplacementandinterstitialcardiacfibrosisincommunitydwellingadultsthemultiethnicstudyofatherosclerosis
AT palakshah associationofcardiactroponintandgrowthdifferentiationfactor15withreplacementandinterstitialcardiacfibrosisincommunitydwellingadultsthemultiethnicstudyofatherosclerosis
AT leonardilkhanoff associationofcardiactroponintandgrowthdifferentiationfactor15withreplacementandinterstitialcardiacfibrosisincommunitydwellingadultsthemultiethnicstudyofatherosclerosis
AT robertchristenson associationofcardiactroponintandgrowthdifferentiationfactor15withreplacementandinterstitialcardiacfibrosisincommunitydwellingadultsthemultiethnicstudyofatherosclerosis
AT joaoalima associationofcardiactroponintandgrowthdifferentiationfactor15withreplacementandinterstitialcardiacfibrosisincommunitydwellingadultsthemultiethnicstudyofatherosclerosis
AT stephenseliger associationofcardiactroponintandgrowthdifferentiationfactor15withreplacementandinterstitialcardiacfibrosisincommunitydwellingadultsthemultiethnicstudyofatherosclerosis